Placebo-controlled trials with Japanese diabetes patients have shown that DPP-4 inhibitors are not likely to cause hypoglycemia [5,6,7,8,9,10,11,12,13,14,15,16]. The gene discussed is DPP4; the disease is diabetes mellitus.